AMC Tytgat Institute, Meibergdreef 69-71, 1105 BK Amsterdam, The Netherlands.
Drug Metab Dispos. 2012 Mar;40(3):515-21. doi: 10.1124/dmd.111.041731. Epub 2011 Dec 13.
Some cephalosporins, such as cefadroxil, are orally available. H(+)-coupled peptide transporter 1 mediates the transport of cephalosporins across the apical membrane of enterocytes. It is not known which mechanism(s) is responsible for the subsequent transport of cephalosporins across the basolateral membrane toward the circulation. We have tested whether ATP-binding cassette (ABC) transporters ABCC3 and/or ABCC4 are involved in the latter process. Transport experiments with plasma membrane vesicles expressing these transporters were used to determine whether ABCC3 and ABCC4 can transport cephalosporins in vitro. The involvement of Abcc3 and Abcc4 in the transport of cefadroxil from enterocytes was subsequently studied using intestinal explants from wild-type, Abcc3(-/-), Abcc4(-/-), and Abcc3(-/-)/Abcc4(-/-) mice in an Ussing chamber setup. Finally, appearance of cefadroxil in portal blood was investigated in vivo after intrajejunal administration of cefadroxil in wild-type, Abcc3(-/-), Abcc4(-/-), and Abcc3(-/-)/Abcc4(-/-) mice. ABCC3- and ABCC4-mediated transport of estradiol-17β-glucuronide was dose-dependently inhibited by cephalosporins in vesicular transport experiments. Furthermore, transport of cefadroxil by ABCC3 and ABCC4 was saturable with K(m) values of 2.5 ± 0.7 and 0.25 ± 0.07 mM, respectively. Transport of cefadroxil from the apical to the basolateral side of jejunal tissue explants was unchanged in Abcc3(-/-) but significantly reduced (approximately 2-fold) in Abcc4(-/-) and Abcc3(-/-)/Abcc4(-/-) when compared with wild-type tissue. Upon instillation of cefadroxil in the jejunum, portal and peripheral blood concentrations were similar in Abcc3(-/-) and Abcc4(-/-) but approximately 2-fold reduced in Abcc3(-/-)/Abcc4(-/-) compared with wild-type mice. Our data demonstrate that intestinal absorption of cefadroxil depends partly on ABCC3 and ABCC4.
一些头孢菌素,如头孢羟氨苄,可口服。H(+)-偶联肽转运体 1 介导头孢菌素穿过肠上皮细胞的顶膜转运。目前尚不清楚哪种机制负责头孢菌素随后穿过基底外侧膜向循环系统的转运。我们已经测试了 ABC 转运体 ABCC3 和/或 ABCC4 是否参与了后一过程。使用表达这些转运体的质膜囊泡进行转运实验,以确定 ABCC3 和 ABCC4 是否可以在体外转运头孢菌素。随后使用野生型、Abcc3(-/-)、Abcc4(-/-)和 Abcc3(-/-)/Abcc4(-/-)小鼠的肠外植体在 Ussing 室设置中研究 Abcc3 和 Abcc4 在外胚层细胞中对头孢羟氨苄的转运中的作用。最后,在野生型、Abcc3(-/-)、Abcc4(-/-)和 Abcc3(-/-)/Abcc4(-/-)小鼠的空肠内给予头孢羟氨苄后,在体内研究了头孢羟氨苄在门静脉血液中的出现情况。在囊泡转运实验中,头孢菌素剂量依赖性地抑制雌二醇-17β-葡糖苷酸的 ABCC3 和 ABCC4 转运。此外,ABCC3 和 ABCC4 对头孢羟氨苄的转运是饱和的,K(m) 值分别为 2.5±0.7 和 0.25±0.07 mM。与野生型组织相比,Abcc3(-/-)中的头孢羟氨苄从顶端到基底外侧的组织外植体转运没有改变,但在 Abcc4(-/-)和 Abcc3(-/-)/Abcc4(-/-)中显著降低(约 2 倍)。在空肠内给予头孢羟氨苄后,Abcc3(-/-)和 Abcc4(-/-)小鼠的门静脉和外周血浓度相似,但 Abcc3(-/-)/Abcc4(-/-)小鼠的浓度比野生型小鼠降低约 2 倍。我们的数据表明,头孢羟氨苄的肠道吸收部分依赖于 ABCC3 和 ABCC4。